Co-amoxiclav
From Biocrawler, the free encyclopedia.
Co-amoxiclav is the British Approved Name, in the British Pharmacopoeia, for the combination antibiotic containing amoxicillin and clavulanic acid. This name, unlike co-trimoxazole, has not been widely adopted internationally and the combination product is usually referred to by various names such as amoxicillin with clavulanic acid or amoxicillin+clavulanate or simply by the trade name. Co-amoxiclav is currently marketed by GlaxoSmithKline under the trade name Augmentin®.
The combination of amoxicillin, a β-lactam antibiotic; with clavulanic acid, a β-lactamase inhibitor; results in an antibiotic with an increased spectrum of action and restored efficacy against β-lactamase producing amoxicillin-resistant bacteria.
Dosage
- Co-amoxiclav sensitive organisms
| ADULTS: | ||||
| PRODUCT | UPPER RESPIRATORY TRACT INFECTIONS | LOWER RESPIRATORY TRACT INFECTIONS | URINARY TRACT INFECTIONS | SKIN AND SOFT TISSUE INFECTIONS |
| AUGMENTIN 375 | 1 - 2 tablets 8 hourly | 1 - 2 tablets 8 hourly | 1 - 2 tablets 8 hourly | 1 - 2 tablets 8 hourly |
| AUGMENTIN 625 | 1 tablet 8 hourly | 1 tablet 8 hourly | 1 tablet 8 hourly | 1 tablet 8 hourly |
| AUGMENTIN BD | 1 tablet 12 hourly | 1 tablet 12 hourly | 1 tablet 12 hourly | 1 tablet 12 hourly |
Side effects
Amongst the possible side-effects of this medication are diarrhoea, vomiting and a few other conditions. Those usually don't need medical attention. However, if the patient experiences an allergic reaction to the medication or severe diarrhoea, it is necessary to contact a doctor immediately.
External links
- Augmentin Homepage (http://www.augmentin.com)
- Augmentin Fact Sheet (http://www.duchs.com/information/Augmentin)
 | This medical treatment article is a stub. You can help Biocrawler by expanding it (http://www.biocrawler.com/w/index.php?title=Co-amoxiclav&action=edit). |
